Blebbistatin as a novel antiviral agent targeting equid herpesvirus type 8.
Authors: Li Liangliang, Cui Xiu, Yu Yue, Sun Qi, Li Wenjing, Li Yubao, Li Shuwen, Chen Li, Khan Muhammad Zahoor, Wang Changfa, Wang Tongtong
Journal: Frontiers in veterinary science
Summary
# Blebbistatin: A Potential Game-Changer for EqHV-8 Control Equid herpesvirus type 8 (EqHV-8) continues to challenge equine practitioners, causing reproductive failure and respiratory disease in horses and donkeys whilst lacking any proven pharmacological or immunological countermeasures. Researchers investigating novel antiviral approaches identified blebbistatin—a non-muscle myosin II inhibitor—as a candidate compound and evaluated its efficacy against EqHV-8 through in vitro viral replication assays. The compound demonstrated significant inhibition of viral replication with a dose-dependent response, offering a new mechanistic approach to viral suppression that differs fundamentally from conventional antivirals. For equine professionals managing EqHV-8 outbreaks, these findings represent preliminary evidence warranting further translational research into in vivo efficacy, safety profiles, and bioavailability before clinical application can be considered. Whilst blebbistatin remains experimental, its identification as an active agent against EqHV-8 opens a research pathway that may eventually supplement existing biosecurity and management protocols for controlling this economically important pathogen.
Read the full abstract on PubMed
Practical Takeaways
- •This in vitro research may lead to future treatment options for EqHV-8, an economically significant pathogen currently without effective pharmacological management
- •Blebbistatin represents a potential new therapeutic avenue if in vivo efficacy can be established, addressing a significant gap in equine herpesvirus treatment
- •Further clinical trials needed before any practical application in working horses and donkeys
Key Findings
- •Blebbistatin demonstrates antiviral activity against equid herpesvirus type 8 in vitro
- •EqHV-8 causes significant economic losses in donkey and equine industries with no current effective treatment options
- •Novel mechanism of action targeting viral replication through non-muscle myosin II inhibition